Longitudinal automated brain volumetry vs. expert visual assessment of atrophy progression on MRI is robust but caution is advised

Max Gebest,Christel Weiss,Chang Gyu Cho,Lucrezia Hausner,Lutz Froelich,Alex Foerster,Nandhini Santhanam,Johann Fontana,Christoph Groden,Holger Wenz,Mate E. Maros
DOI: https://doi.org/10.1101/2024.05.21.24306349
2024-05-21
Abstract:Automated tools have been proposed to quantify brain volume for suspected dementia diagnoses. However, their robustness in longitudinal, real-life cohorts remains unexplored. We investigated if expert visual assessment (EVA) of atrophy progression is reflected by automated volumetric analyses (AVA) on sequential MR-imaging. We analyzed a random subset of 20 patients with two consecutive 3D T1-weighted examinations (median follow-up 4.0 years, LQ-UQ: 2.1-5.2, range: 0.2-10). Thirteen (65%) with cognitive decline, the remaining with other neuropsychiatric diseases. EVA was performed by two blinded neuroradiologists using a 3 or 5-point Likert scale for atrophy progression (scores -/+0-2: no, probable and certain progression or decrease, respectively) in dementia-relevant brain regions (frontal-, parietal-, temporal lobes, hippocampi, ventricles). Differences of AVA-volumes were normalized to baseline (delta). Inter-rater agreement of EVA scores was excellent (K=0.92). AVA-delta and EVA showed significant global associations for the right hippocampus (p=0.035), left temporal lobe (p=0.0092), ventricle volume (p=0.0091) and a weak association for the parietal lobe (p=0.067). Post hoc testing revealed a significant link for the left hippocampus (p=0.039). In conclusion, the associations between volumetric deltas and EVA of atrophy progression were robust for certain brain regions. However, AVA-deltas showed unexpected variance, and therefore should be used with caution in individual cases, especially when acquisition protocols vary.
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the robustness and consistency of Automated Volumetric Analyses (AVA) and Expert Visual Assessment (EVA) in evaluating brain atrophy progression in longitudinal, real - world cohorts. Specifically, the researchers want to verify whether the automated tools can accurately reflect the brain atrophy progression obtained by experts through visual assessment, especially how the automated tools perform in multiple scans under different MRI scanners and protocols. ### Main research questions: 1. **Robustness of automated tools**: How do automated brain volumetric measurement tools perform in longitudinal, real - world cohorts? Can these tools consistently detect changes in brain atrophy in MRI images at different time points? 2. **Consistency with expert assessment**: Are the volume changes (delta) generated by automated tools consistent with the atrophy progression scores (EVA) obtained by experts through visual assessment? In which specific brain regions (such as the right hippocampus, left temporal lobe, ventricular system), is this consistency more significant? 3. **Technical limitations and precautions**: Are there any technical limitations when using automated tools for longitudinal assessment? How do these limitations affect the interpretation of results and clinical applications? ### Research background: - **Aging society**: With the aging of the population, the socioeconomic burden caused by cognitive and memory decline is increasing day by day. - **The role of MRI in diagnosis**: Structural MRI is the main imaging method for the early diagnosis of cognitive decline. - **Development of automated tools**: In recent years, many automated brain segmentation and volumetric analysis tools have been developed to make up for the deficiencies of subjective visual assessment and assist neuroradiologists in making diagnoses more quickly. - **Existing challenges**: Although these tools have theoretical advantages, their robustness in longitudinal settings and consistency with expert assessment have not been fully verified. ### Research methods: - **Study population**: 20 patients were randomly selected, and each patient had at least two consecutive 3D T1 - weighted MRI examinations. - **Expert Visual Assessment (EVA)**: Two independent and blinded radiologists scored the atrophy progression in specific brain regions using a 3 - or 5 - point Likert scale. - **Automated Volumetric Analysis (AVA)**: The AI - Rad Companion Brain MR tool was used to perform automatic segmentation and volume measurement on 3D T1 - weighted MRI images. - **Statistical analysis**: The association between EVA and AVA was evaluated by non - parametric tests (Kruskal - Wallis test and Wilcoxon signed - rank test), and multiple - testing correction was performed. ### Research results: - **Main findings**: The study found that there was a significant association between volume changes in the right hippocampus, left temporal lobe, and ventricular system and expert visual assessment. However, the automated tools showed high variability and inconsistency in some cases, especially in multiple scans under different MRI scanners and protocols. - **Technical limitations**: In some cases, even when experts did not observe atrophy progression, the automated tools still showed large volume changes, indicating that caution is required when using automated tools and comprehensive judgment should be made in combination with expert visual assessment. ### Conclusions: - **Potential value of automated tools**: Automated tools show good consistency in evaluating volume changes in some brain regions (such as the right hippocampus, left temporal lobe, and ventricular system), which is helpful for auxiliary diagnosis. - **Technical limitations**: Automated tools have certain technical limitations in longitudinal assessment. Especially when used under different MRI scanners and protocols, the robustness of the results is affected. - **Future directions**: Future research needs to further verify the performance of automated tools in larger - scale and longer - time - span cohorts and explore how to optimize these tools to improve their reliability in clinical applications. In conclusion, this study emphasizes the need for caution when using automated brain volumetric measurement tools and making comprehensive judgments in combination with expert visual assessment to ensure the accuracy and reliability of diagnosis.